# Cilia-CSF Research Program Dashboard

## Project Overview
**Project**: Motile Cilia-CSF Flow in Idiopathic Scoliosis  
**Status**: Implementation Phase  
**Start Date**: December 2024  
**Target Completion**: June 2026  
**Budget**: $750,000  

## Current Status Summary

### Phase 1: Protocol Development & Validation (Weeks 1-4)
**Status**: üü° In Progress  
**Completion**: 25%  

#### Completed Tasks ‚úÖ
- [x] Draft revised aims incorporating cilia-CSF framework
- [x] Create comprehensive implementation guide
- [x] Develop zebrafish motile cilia SOPs
- [x] Design clinical study protocol template

#### In Progress Tasks üü°
- [ ] Circulate protocol draft for feedback (Due: D+7)
- [ ] Order zebrafish reagents and lines (Due: D+10)
- [ ] Reserve instrumentation time slots (Due: D+12)

#### Pending Tasks ‚è≥
- [ ] Complete PTK7 rescue pilot study (Due: D+21)
- [ ] Finalize MRI protocols (Due: D+25)
- [ ] Submit IRB amendments (Due: D+28)

### Phase 2: Clinical Study Setup (Weeks 3-6)
**Status**: üî¥ Not Started  
**Completion**: 0%  

#### Key Milestones
- [ ] Clinical kickoff meeting (Due: D+18)
- [ ] MRI protocol harmonization (Due: D+25)
- [ ] Biospecimen workflow setup (Due: D+30)
- [ ] REDCap database deployment (Due: D+35)

### Phase 3: Regulatory & Data Management (Weeks 4-7)
**Status**: üî¥ Not Started  
**Completion**: 0%  

#### Key Milestones
- [ ] IRB approval (Due: D+35)
- [ ] Data management infrastructure (Due: D+42)
- [ ] Quality assurance systems (Due: D+45)

## Detailed Task Tracking

### Week 1-2: Protocol Development
| Task | Owner | Status | Due Date | Notes |
|------|-------|--------|----------|-------|
| Draft revised aims | D. Grimes | ‚úÖ Complete | D+2 | Framework established |
| Map inclusion criteria | D. Grimes | ‚úÖ Complete | D+4 | Criteria defined |
| Circulate for feedback | Project Manager | üü° In Progress | D+7 | Awaiting responses |
| Collect feedback | Project Manager | ‚è≥ Pending | D+8 | Meeting scheduled |
| Submit revisions | Regulatory | ‚è≥ Pending | D+14 | Draft ready |

### Week 2-4: Zebrafish Assay Setup
| Task | Owner | Status | Due Date | Notes |
|------|-------|--------|----------|-------|
| Order foxj1a lines | Zebrafish Core | üü° In Progress | D+10 | PO submitted |
| Prepare mRNA backup | C. Boswell | ‚è≥ Pending | D+12 | Protocol ready |
| Reserve confocal time | Imaging Core | üü° In Progress | D+12 | Slots identified |
| Reserve SEM time | Imaging Core | ‚è≥ Pending | D+14 | Monthly slots |
| Reserve ŒºCT time | Imaging Core | ‚è≥ Pending | D+14 | Weekly slots |
| Finalize SOPs | C. Boswell | ‚úÖ Complete | D+15 | SOPs documented |
| PTK7 pilot study | C. Boswell | ‚è≥ Pending | D+21 | Reagents ordered |

### Week 3-4: Clinical Coordination
| Task | Owner | Status | Due Date | Notes |
|------|-------|--------|----------|-------|
| Schedule kickoff | Project Manager | üü° In Progress | D+18 | Invites sent |
| Prepare pre-read | Project Manager | ‚è≥ Pending | D+20 | Materials ready |
| Conduct meeting | All Stakeholders | ‚è≥ Pending | D+22 | Agenda set |
| Draft MRI protocols | Radiology Lead | ‚è≥ Pending | D+25 | Templates ready |
| Test-retest plan | Radiology Lead | ‚è≥ Pending | D+30 | Protocol needed |

### Week 4-6: Regulatory Setup
| Task | Owner | Status | Due Date | Notes |
|------|-------|--------|----------|-------|
| Update consent docs | Regulatory | ‚è≥ Pending | D+25 | Templates ready |
| Submit IRB amendments | Regulatory | ‚è≥ Pending | D+28 | Draft complete |
| Draft data agreements | Legal | ‚è≥ Pending | D+30 | Templates ready |
| Set up REDCap | Data Manager | ‚è≥ Pending | D+35 | Requirements defined |

## Resource Allocation

### Personnel Assignments
| Role | Name | Effort | Status | Key Responsibilities |
|------|------|--------|--------|---------------------|
| Principal Investigator | D. Grimes | 10% | Active | Protocol oversight, data interpretation |
| Zebrafish Lead | C. Boswell | 50% | Active | Assay development, pilot studies |
| Clinical Lead | R. Boswell | 25% | Active | Clinical coordination, MRI protocols |
| Data Manager | N. Morante | 50% | Active | Database setup, quality control |
| Regulatory Lead | [TBD] | 25% | Pending | IRB submissions, compliance |
| Statistician | [TBD] | 25% | Pending | Analysis planning, power calculations |

### Budget Tracking
| Category | Allocated | Spent | Remaining | Status |
|----------|-----------|-------|-----------|--------|
| Personnel | $300,000 | $15,000 | $285,000 | On track |
| Equipment | $200,000 | $5,000 | $195,000 | On track |
| Supplies | $150,000 | $2,000 | $148,000 | On track |
| Travel | $50,000 | $0 | $50,000 | On track |
| Other | $50,000 | $1,000 | $49,000 | On track |
| **Total** | **$750,000** | **$23,000** | **$727,000** | **On track** |

## Risk Assessment

### High-Risk Items
| Risk | Impact | Probability | Mitigation | Owner |
|------|--------|-------------|------------|-------|
| Zebrafish line availability | High | Medium | Backup reagents, cryostocks | C. Boswell |
| MRI protocol harmonization | High | Low | Early radiology engagement | R. Boswell |
| IRB approval delays | Medium | Medium | Parallel document prep | Regulatory |
| Clinical recruitment challenges | Medium | Medium | Multiple sites, flexible windows | R. Boswell |

### Medium-Risk Items
| Risk | Impact | Probability | Mitigation | Owner |
|------|--------|-------------|------------|-------|
| Instrument scheduling conflicts | Medium | Medium | Backup slots, flexible scheduling | Imaging Core |
| Data integration complexity | Medium | Low | Early database design | N. Morante |
| Staff turnover | Low | Medium | Cross-training, documentation | Project Manager |

## Quality Metrics

### Assay Validation Targets
| Metric | Target | Current | Status |
|--------|--------|---------|--------|
| PTK7 rescue success rate | ‚â•80% | TBD | Pending |
| CSF velocity reproducibility | CV <10% | TBD | Pending |
| ŒºCT angle measurement accuracy | ¬±2¬∞ | TBD | Pending |
| Inter-observer reliability | ICC >0.8 | TBD | Pending |

### Clinical Study Targets
| Metric | Target | Current | Status |
|--------|--------|---------|--------|
| Recruitment rate | 10/month | 0 | Not started |
| MRI completion rate | ‚â•95% | TBD | Pending |
| Follow-up retention | ‚â•90% | TBD | Pending |
| Data quality score | ‚â•95% | TBD | Pending |

## Communication Plan

### Regular Meetings
| Meeting | Frequency | Participants | Purpose |
|---------|-----------|--------------|---------|
| Project Team | Weekly (Fridays) | All team members | Progress updates, issue resolution |
| Scientific Advisory | Monthly | External experts | Scientific guidance, peer review |
| Data Safety Monitoring | Quarterly | Independent experts | Safety review, protocol oversight |
| Stakeholder Update | Bi-monthly | Leadership, funders | High-level progress reporting |

### Reporting Schedule
| Report | Frequency | Recipients | Content |
|--------|-----------|------------|---------|
| Weekly Status | Weekly | Project team | Task completion, issues, next steps |
| Monthly Progress | Monthly | Leadership | Milestone achievement, budget status |
| Quarterly Review | Quarterly | Funders, advisors | Scientific progress, publications |
| Annual Report | Annually | All stakeholders | Comprehensive project summary |

## Next Actions (This Week)

### Immediate Priorities
1. **Complete protocol circulation** - Send draft to all stakeholders
2. **Finalize zebrafish orders** - Confirm reagent availability and delivery
3. **Schedule clinical kickoff** - Confirm meeting time and agenda
4. **Begin IRB preparation** - Start consent document updates

### Upcoming Deadlines
- **D+7**: Protocol feedback deadline
- **D+10**: Zebrafish reagent delivery
- **D+14**: IRB amendment submission
- **D+18**: Clinical kickoff meeting

## Success Criteria

### Phase 1 Success Metrics
- [ ] All protocol revisions approved by stakeholders
- [ ] PTK7 rescue pilot demonstrates ‚â•80% success rate
- [ ] All instrumentation time slots reserved
- [ ] IRB amendments submitted

### Phase 2 Success Metrics
- [ ] Clinical kickoff meeting completed
- [ ] MRI protocols finalized and validated
- [ ] Biospecimen workflow operational
- [ ] REDCap database deployed

### Phase 3 Success Metrics
- [ ] IRB approval obtained
- [ ] Clinical recruitment initiated
- [ ] Quality assurance systems operational
- [ ] All assays validated and ready for production

## Contact Information

### Key Personnel
- **Project Manager**: [Name], [Email], [Phone]
- **Principal Investigator**: D. Grimes, [Email], [Phone]
- **Zebrafish Lead**: C. Boswell, [Email], [Phone]
- **Clinical Lead**: R. Boswell, [Email], [Phone]
- **Data Manager**: N. Morante, [Email], [Phone]

### External Contacts
- **Zebrafish Core**: [Contact], [Email], [Phone]
- **Imaging Core**: [Contact], [Email], [Phone]
- **Radiology Lead**: [Contact], [Email], [Phone]
- **Regulatory Office**: [Contact], [Email], [Phone]

---

**Last Updated**: December 2024  
**Next Review**: Weekly  
**Dashboard Owner**: Project Manager

